Landscape Capital Management L.L.C. Makes New Investment in Kenvue Inc. (NYSE:KVUE)

Landscape Capital Management L.L.C. bought a new stake in Kenvue Inc. (NYSE:KVUE) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 26,426 shares of the company’s stock, valued at approximately $611,000.

Several other hedge funds and other institutional investors also recently modified their holdings of KVUE. Advisors Asset Management Inc. boosted its stake in shares of Kenvue by 8.3% in the 3rd quarter. Advisors Asset Management Inc. now owns 20,371 shares of the company’s stock valued at $471,000 after purchasing an additional 1,559 shares in the last quarter. NS Partners Ltd boosted its position in Kenvue by 1.8% in the third quarter. NS Partners Ltd now owns 509,075 shares of the company’s stock valued at $11,775,000 after buying an additional 9,240 shares in the last quarter. Segall Bryant & Hamill LLC bought a new stake in shares of Kenvue during the third quarter worth $516,000. PNC Financial Services Group Inc. increased its holdings in shares of Kenvue by 1.8% during the third quarter. PNC Financial Services Group Inc. now owns 422,666 shares of the company’s stock worth $9,776,000 after buying an additional 7,664 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of Kenvue in the 3rd quarter valued at $2,586,000. Institutional investors own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on KVUE. Piper Sandler boosted their price objective on Kenvue from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Monday, September 23rd. JPMorgan Chase & Co. upped their price objective on Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Jefferies Financial Group initiated coverage on shares of Kenvue in a research report on Tuesday, September 24th. They set a “buy” rating and a $27.00 target price on the stock. Bank of America upped their price target on shares of Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Tuesday, October 22nd. Finally, UBS Group lifted their price target on shares of Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, Kenvue currently has an average rating of “Hold” and a consensus price target of $22.64.

Kenvue Stock Performance

KVUE stock opened at $24.08 on Friday. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $24.31. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The stock has a 50-day moving average price of $22.84 and a 200-day moving average price of $20.86. The firm has a market cap of $46.17 billion, a PE ratio of 43.78, a price-to-earnings-growth ratio of 2.19 and a beta of 1.36.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.01. The firm had revenue of $3.90 billion for the quarter, compared to analyst estimates of $3.92 billion. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The company’s revenue was down .4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.31 earnings per share. As a group, equities research analysts expect that Kenvue Inc. will post 1.07 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th will be paid a $0.205 dividend. This represents a $0.82 annualized dividend and a yield of 3.41%. The ex-dividend date is Wednesday, November 13th. Kenvue’s dividend payout ratio (DPR) is currently 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.